The difficult life of people with bleeding disorders began to change in Morocco thanks to collaboration between the WFH Humanitarian Aid Program, the Moroccan Hemophilia Association (the national member organization (NMO) in the country), healthcare professionals, treatment centres, and national authorities. Mohammad El Khorassani, MD, a professor of pediatric hematology and supervisor of the Hemophilia Treatment Centre of Children’s Hospital of Rabat, recalled his first experience with the WFH: “When I first got in touch with the WFH and when they came to Morocco… we were at a stage where we had very little treatment. When the WFH came that first time, I told them, maybe you’ve given us a glimmer of hope. You’ve opened a door for us.”
The WFH has been working in partnership with the ministry of health (MOH) and the NMO in Morocco for many years—always with the goal of helping the country along the road to sustainable care. Over the years, this partnership has included programmatic support delivered through the WFH Global Alliance for Progress (GAP) Program; a WFH Hemophilia Organization (HOT) Twinning between Morocco and France; a WFH Hemophilia Treatment Organization (HTC) Twinning; and through country programs. In recent years, the WFH and Morocco collaborated closely on capacity building for healthcare practitioners, including training hematologists, nurses, musculoskeletal professionals, and laboratory specialists. Efforts have also been made to strengthen the policy dialogue with the Direction de l’Epidémiologie et de Lutte contre les Maladies in the Ministry of Health; these efforts are supporting the objectives of the Moroccan national care program for bleeding disorders. Morocco has recently been selected to take part in the WFH Path to Access to Care and Treatment (PACT) Program, from 2026-2030, to further improve access to care and treatment.
Before the WFH, people with hemophilia in Morocco faced major barriers to treatment. Hassan Mrani Alaoui, President of the Moroccan Hemophilia Association, and a person with hemophilia, remembers a time when factor treatment was nearly non-existent. Limited supplies later became available, but only for a small number of patients with health insurance, leaving many others without access.
Once regular donations made treatment products consistently obtainable, patients, families, and healthcare professionals saw the difference that access to factor could make. The impact of donations—as well as training provided by the WFH—helped show national institutions that sustained treatment could improve health outcomes and reduce the burden of bleeding episodes on people and on healthcare institutions.
Now, with the donations, people are getting regular access to treatment products, and it is becoming a part of their lives. Even the Ministry of Health has noticed this change. Initially we first got treatment products just from the WFH. And now the Ministry buys it, too.
—Hassan Mrani Alaoui, President of the Moroccan Hemophilia Association and a person with hemophilia
Over time, this progress encouraged a broader national commitment. The Ministry of Health and university hospitals began purchasing treatment products, helping move the country from reliance on donations toward a more sustainable model of care. This shift marked an important step in ensuring that people with hemophilia could receive treatment more consistently, and, eventually, at home.
Care has improved enough that the Hemophilia Treatment Center of the Children’s Hospital of Rabat has received several awards, including recognition as best treatment centre and as for offering the best government institution support for hemophilia—achievements made possible thanks to the support of the WFH and the WFH Humanitarian Aid Program. The centre has participated in national and international congresses, and is recognized across the Middle East, and worldwide.
For children like Adam, this progress has meant fewer limitations and more freedom. The youth can play, walk, and spend time outdoors with the confidence that comes with knowing that a small injury won’t be debilitating. Activities that once carried fear and risk—such as playing with friends or spending time near the family’s animals—have become more manageable with access to treatment.
Hassan Mrani Alaoui, President of the Moroccan Hemophilia Association, sums up the relationship between the Moroccan inherited bleeding disorders community and the WFH as a deep one: “For years now, we’ve been part of the WFH, and they’ve always been there with us and supported us. We have a relationship now with the WFH that is almost like family.”
The WFH Humanitarian Aid Program has donated 38.3 million IUs of factor to Morocco since 2015. Over 7.7 million IUs of factor were donated in 2025 alone. To find out more about the Program, please click here.
About the WFH Humanitarian Aid Program
The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and Takeda, our Contributor. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.
